Purpose-driven healthcare leader | Cell & Gene Therapy | Radiopharmaceutical | Biotech & Pharmaceutical | Regulatory Compliance and Transformation
Great webinar hosted by FDA's Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products (OTP)! The discussion revolved around the recently finalized guidance for the development of Chimeric Antigen Receptor (CAR) T cell products, crucial for industry and academic sponsors in this field. The CBER experts highlighted manufacturing, nonclinical, and clinical considerations. Missed the live session? Catch the recording for valuable insights! #FDA #CBER #CAR-T #Biologics #Healthcare #Webinar #Guidance #CellTherapy #GeneTherapy Compliance Architects®
Do you work with CAR T cell products? Have you reviewed #FDA’s final guidance on considerations for the development of CAR T cell products? We recently hosted a webinar to share key takeaways from the guidance and answer questions. Watch the recording📽️ https://bit.ly/49H4zHd